Clinical Trial Update: Use of CBD in the Treatment of Anxiety [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating cannabidiol (CBD) for anxiety disorders, including generalized anxiety disorder and insomnia, and is currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Generalized Anxiety Disorder
• Insomnia

Drugs mentioned

• CBD (cannabidiol)

Snippet

Sponsor: University of Florida | Conditions: Anxiety, Generalized Anxiety Disorder | Phase 2 | Status: RECRUITING